Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective
about
Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancerClaudins in intestines: Distribution and functional significance in health and diseasesClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetInflammatory bowel disease in India - Past, present and futureTranscriptional regulators of claudins in epithelial tight junctionsClaudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic StudiesNovel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.Use of cell-based screening to identify small-molecule compounds that modulate claudin-4 expression.Molecular Characterization of Barrier Properties in Follicle-Associated Epithelium of Porcine Peyer's Patches Reveals Major Sealing Function of Claudin-4.Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells.Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's Disease.Cholinergic receptor activation on epithelia protects against cytokine-induced barrier dysfunction.Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.AIM2 contributes to the maintenance of intestinal integrity via Akt and protects against Salmonella mucosal infection.Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8.Effects of Ex Vivo Infection with ETEC on Jejunal Barrier Properties and Cytokine Expression in Probiotic-Supplemented Pigs.IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis.Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.Innate immune factors in the development and maintenance of pouchitis.Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway.IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.Animal models for studying epithelial barriers in neonatal necrotizing enterocolitis, inflammatory bowel disease and colorectal cancer.Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases.Long-term oral melatonin administration reduces ethanol-induced increases in duodenal mucosal permeability and motility in rats.Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease.Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa
P2860
Q26752750-C4943C44-DBA6-4CDA-8BEB-C39C94C7435CQ27000548-67DB0634-C1A5-44BC-BD75-8A7AB138DF97Q28066092-0434F7AB-2F4D-49CD-A332-B32D14186436Q28079050-7E267F3B-EBC9-4079-8C07-AF0B0AAFFD42Q28261649-C43E2E5D-2E20-4E6A-9FC2-57458C668DB7Q28553898-C743B1CF-E669-4F71-844D-C6C332550224Q34486064-53821939-784F-4019-98BC-D55615D8E1E7Q35212830-8C43D5BB-522B-4C09-A45D-0F81D88C11D3Q35564741-EA631CF1-8930-4EB2-962D-F1221AA3A9B0Q38601443-A9DCB570-4F17-4FE8-8969-70A2B204A75CQ38725996-785B17C2-2C66-418A-9C8C-266662B19149Q38859765-BD21AD82-3CE2-47AE-B56F-B327541DBF61Q38909421-CB04B6DA-5BFD-4E5C-B256-AA7D42CD9E65Q39139171-9A4F9E1A-8F85-456C-8927-0FDBAB41FADAQ39189861-0D5C327C-9073-47ED-AFFA-FF8876B601D1Q40030432-F66CC230-127A-4F94-AB47-165728FD0075Q40352387-630CF6E2-4192-4ECD-9412-CA99C70EF030Q40403098-292A08AE-3D40-4A22-A37C-BA07835E1C30Q43201345-3BBE0AF0-4138-4788-80D1-4AC94FD4C192Q43468115-19593D2F-5251-4DBA-B779-CB49488E3569Q44068457-B6BAA511-EBA3-482F-AA5E-36AED4A779CBQ47165756-B7D997C5-E5B9-4717-AE68-1A8451425070Q47758483-547C61D9-B931-4726-8E9F-E41B4AFD31DDQ47803871-822C1EFA-0D44-4168-AD3B-8AA457913E6FQ47969652-649B131E-B3C3-4E39-9555-80757FC00B49Q52609696-33D7F8E0-AFF6-4679-BB68-519CB11689B7Q54199823-A63E0D28-26F5-4AC1-A4FF-DD297CC7D90DQ54269295-50C066DE-D8C7-4A23-9EA1-229DD678D118Q54281028-C413C458-F6A9-45D6-A317-25EC2518EC34Q58799139-5B1F7B7B-1C93-41EC-93DD-F5FAAF086A40
P2860
Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective
description
scientific article published on 01 March 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2012
@uk
name
Comparative tight junction pro ...... uberculosis: a new perspective
@en
Comparative tight junction pro ...... uberculosis: a new perspective
@nl
type
label
Comparative tight junction pro ...... uberculosis: a new perspective
@en
Comparative tight junction pro ...... uberculosis: a new perspective
@nl
prefLabel
Comparative tight junction pro ...... uberculosis: a new perspective
@en
Comparative tight junction pro ...... uberculosis: a new perspective
@nl
P2093
P2860
P1433
P1476
Comparative tight junction pro ...... uberculosis: a new perspective
@en
P2093
Govind K Makharia
Pooja Goswami
Prasenjit Das
Siddhartha Datta Gupta
Subrat K Panda
Tapash K Das
Vineet Ahuja
Vishnubhatla Sreenivas
P2860
P2888
P304
P356
10.1007/S00428-012-1195-1
P50
P577
2012-03-01T00:00:00Z